Schizoaffective Disorders Completed Phase 4 Trials for Clozapine (DB00363)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00498550Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualTreatment
NCT00981526Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With SchizophreniaTreatment
NCT01248195Optimization of Treatment and Management of Schizophrenia in EuropeTreatment
NCT00501618Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective DisorderBasic Science
NCT02640300Switching Antipsychotics: Abrupt Discontinuation Versus OverlapTreatment